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Previous studies identiﬁed 180 single nucleotide polymorphisms (SNPs) associated with adult height,
explaining ∼10% of the variance. The age at which these begin to affect growth is unclear. We modelled
the effect of these SNPs on birth length and childhood growth. A total of 7768 participants in the Avon
Longitudinal Study of Parents and Children had data available. Individual growth trajectories from 0 to
10 years were estimated using mixed-effects linear spline models and differences in trajectories by individual
SNPs and allelic score were determined. The allelic score was associated with birth length (0.026 cm increase
per ‘tall’ allele, SE 5 0.003, P 5 1 3 10
215, equivalent to 0.017 SD). There was little evidence of association
between the allelic score and early infancy growth (0–3 months), but there was evidence of association
between the allelic score and later growth. This association became stronger with each consecutive
growth period, per ‘tall’ allele per month effects were 0.015 SD (3 months–1 year, SE 5 0.004), 0.023 SD
(1–3 years, SE 5 0.003) and 0.028 SD (3–10 years, SE 5 0.003). By age 10, the mean height difference
between individuals with ≤170 versus ≥191 ‘tall’ alleles (the top and bottom 10%) was 4.7 cm (0.8 SD),
explaining ∼5% of the variance. There was evidence of associations with speciﬁc growth periods for
some SNPs (rs3791675, EFEMP1 and rs6569648, L3MBTL3) and supportive evidence for previously reported
age-dependent effects of HHIP and SOCS2 SNPs. SNPs associated with adult height inﬂuence birth length
and have an increasing effect on growth from late infancy through to late childhood. By age 10, they explain
half the height variance (∼5%) of that explained in adults (∼10%).
INTRODUCTION
Twin and family studies have shown adult human height to be
highly heritable (80–90%) (1–3). Twin studies also suggest
that the genetic contribution to height varies throughout child-
hood with birth length and early growth appearing to have
stronger environmental inﬂuences than later growth and
height which appears to be more strongly inﬂuenced by
genetic variation (4).
Many genome-wide association studies (GWASs) have
successfully identiﬁed loci associated with adult height
(5–12). A recent meta-analysis which included 133 653
European subjects in the genome-wide scan and 50 074 sub-
jects in follow-up identiﬁed 180 single nucleotide poly-
morphisms (SNPs) associated with adult height, explaining
 10% of the variation (12). However, none of these
studies has related these SNPs to height growth in child-
hood.
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growth is likely to differ across childhood. Birth size may
be inﬂuenced more by maternal size and the intrauterine
effects of maternal behaviours such as smoking than genetics,
although birth length has been shown (through correlations
with paternal size) to be more genetically inﬂuenced than
other aspects of fetal growth, such as weight (13). Infancy is
then considered to be a canalization period, whereby growth
shifts an infant’s size from their birth size to their genetically
determined size and growth pattern. Thus, in the ﬁrst 2 years
of life, many infants exhibit height centile-crossing, i.e. a
child whose height at one time point sits on a low centile of
the population distribution of height may well have a height
on a higher centile of the population distribution at a later
time point, and vice versa. Later in childhood, height tends
to follow a stable pattern in terms of the centile of the popu-
lation distribution, which is assumed to be the genetically
determined growth pattern (14). Thus, it is possible that
genetic variation has relatively less inﬂuence on birth length
and growth in infancy, and more inﬂuence on growth later
in childhood. This, however, has not yet been empirically
tested using data from longitudinal cohort studies and SNPs
identiﬁed from GWAS.
A recent study of 3538 individuals (15) took 48 height-
associated SNPs and evaluated their associations with several
features of growth: adult height, peak height velocity in
infancy (PHV1) and peak height velocity in puberty (PHV2).
They formally tested all SNPs for an interaction with age
(infancy versus puberty) and found evidence of such an inter-
action with four SNPs—rs10946808 (HIST1H1D) and
rs6854783 (HHIP) which were most strongly associated with
PHV1 and rs11107116 (SOCS2) and rs12459350 (DOT1L)
which were most strongly associated with PHV2. Of these,
they described previous biological evidence that supported
their ﬁndings for the age interactions with HHIP and SOCS2.
That study therefore demonstrates that the SNPs identiﬁed in
the adult study are associated with growth patterns in infancy
and that they may affect different time periods. However, that
study focussed on growth patterns at two sensitive time
periods, infancy and puberty, and did not explore associations
of the SNPs with rates of growth between infancy and puberty
or the association between these SNPs and birth size. Another
recent study analysed the association between SNPs from 46
previouslyreportedadultheightlociinchildrenandfoundnom-
inallysigniﬁcantassociationsfor15loci(16),butthatstudyana-
lysed together all children between the ages of 0 and 18 years
(preventing identiﬁcation of age-speciﬁc effects) and does not
have repeat measures on the same children. It therefore
remains unclear at what age in childhood the adult height
SNPs begin to affect growth.
In this study, we examine the association of the 180 height
SNPs identiﬁed in the original GWAS of European adults (12)
(and the combined allelic score of these) on birth length and
individual growth trajectories from birth to age 10 in the
Avon Longitudinal Study of Parents and Children
(ALSPAC) cohort. We also test the hypothesis that the associ-
ations differ according to birth length.
RESULTS
Data on growth and genotypes were available for 3994 boys
and 3774 girls (55% of the total ALSPAC cohort—differences
between those included and excluded are shown in Sup-
plementary Material, Table S1). There were a median of
eight measurements per child (inter-quartile range 6–11
measurements), with most children having measurements
across each of the growth periods (Supplementary Material,
Table S2).
There was an association of the allelic score with birth
length [each ‘tall’ allele increases birth length by 0.026 cm
(95% CI 0.020–0.033) P ¼ 1 × 10
215] (Table 1 and Sup-
plementary Material, Table S4). In a regression of birth
length on allelic score (adjusting for sex), there was little stat-
istical evidence for a sex difference (interaction P ¼ 0.158).
The allelic score explained  2% of the variation in birth
length (R
2¼ 0.017).
There was no association between the allelic score and early
growth (0–3 months), but there was increasing evidence for an
association with growth in the next three periods. Each ‘tall’
allele increases growth by 0.0021 cm (95% CI 0.0009–
0.0032) or 0.015 SD per month between 3 months and
1 year (P ¼ 0.0003), by 0.0017 cm (95% CI 0.0013–0.0021)
or 0.023 SD per month between 1 and 3 years (P ¼ 6 ×
10
217), and by 0.0010 cm (95% CI 0.0009–0.0012) or 0.028
SD per month between 3 and 10 years (P ¼ 2 × 10
237)
(Table 1 and Supplementary Material, Table S4). Aggregated
over the 3 months to 10 years period, this translates into a
0.14 cm growth difference per ‘tall’ allele. In a regression of
height at age 10 on the allelic score (adjusting for sex), each
tall allele was associated with an increase in height of
0.16 cm (95% CI 0.14–0.17, P ¼ 6 × 10
290), with little stat-
istical evidence for a sex difference (interaction P ¼ 0.78).
The allelic score explained  5% of the variation in height
at age 10 (R
2¼ 0.051).
Table 1. Association results for the allelic score and birth length and growth
Birth length 0–3 months 3 months–1 year 1–3 years 3–10 years
Mean birth length, cm (SD) or growth rate, cm per month (SD) 50.49 (1.525) 3.73 (0.232) 1.64 (0.139) 0.81 (0.074) 0.53 (0.036)
Beta coefﬁcients (SE), in cm 0.0264 (0.0033) 0.0020 (0.0015) 0.0021 (0.0006) 0.0017 (0.0002) 0.0010 (0.0001)
Beta coefﬁcients (SE), in SD 0.0173 (0.0022) 0.0086 (0.0065) 0.0151 (0.0043) 0.0230 (0.0027) 0.0278 (0.0028)
P-values 1 × 10
215 0.175 3 × 10
24 6 × 10
217 2 × 10
237
Coefﬁcients (standard error) are reported as the cm and SD mean difference in birth length or growth per month per ‘tall’ allele. The between growth periods
heterogeneity P-value was P ¼ 0.0004.
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10 years, by allelic score show approximate linear relation-
ships (Fig. 1). The mean height difference between individuals
with 170 or fewer ‘tall’ alleles (representative of the bottom
10% of individuals’ allelic score in our population) and indi-
viduals with 191 or more ‘tall’ alleles (representative of the
top 10%) at age 10 is 4.7 cm (or 0.8 SD) (full growth trajec-
tories for simulated 10th and 90th centile individuals are
shown in Supplementary Material, Fig. S1).
Only two individual SNPs showed a signiﬁcant association
(P , 5.6 × 10
25) for either birth length or a growth period
(Supplementary Material, Table S4). The C allele of
rs3791675, in the EFEMP1 gene, was associated with an
increased growth rate of 0.0048 cm (95% CI 0.0026–0.0071,
P ¼ 2 × 10
25) per tall allele per month in the fourth growth
period (3–10 years). This SNP also showed some evidence
for an association (P ¼ 0.001) in the third growth period
(1–3 years), but little evidence for association with birth
length or the ﬁrst two growth periods (though heterogeneity
by growth period P ¼ 0.104). The C allele of rs6569648, in
the L3MBTL3 gene, was associated with an increased birth
length of 0.19 cm per tall allele (95% CI 0.10–0.28,
P ¼ 3 × 10
25), but there was little evidence for association
with any of the four growth periods (heterogeneity by
growth period P ¼ 0.017). However, there were no signiﬁcant
differences between growth periods for any of the SNPs (het-
erogeneity P . 0.0003 for all SNPs, Supplementary Material,
Table S4) and we may have low power for these individual
SNP analyses.
A previous study (15) has reported an interaction with age
for four of the loci studied here (HIST1H1D, HHIP, SOCS2
and DOT1L). We found some evidence of an association
(0.009 cm per C allele per month, P ¼ 0.003) in the expected
direction in the third growth period (1–3 years) for rs7689420
in the HHIP gene, but no association (P ¼ 0.198) with growth
in later childhood (3–10 years), although there was little stat-
istical evidence of heterogeneity by growth period (P ¼ 0.214)
(Supplementary Material, Table S2). We found some evidence
of an association (0.004 cm per T allele per month, P ¼ 4 ×
10
24) in the fourth growth period (3–10 years) for
rs11107116 near the SOCS2 gene, but little evidence for
association with birth length (P ¼ 0.352) or growth during
infancy (ﬁrst 3 growth periods all P-values . 0.25). There
was suggestive statistical evidence for heterogeneity by
growth period for this SNP (P ¼ 0.020) (Supplementary
Material, Table S2). However, we found little evidence of
association between rs806794 (in the histone cluster) or
rs12982744 (in the DOT1L gene) and birth length, or any
of the growth periods (and heterogeneity by growth periods
were P ¼ 0.857 and P ¼ 0.691, respectively).
Although we have low power to detect associations with
individual SNPs in each growth period, when we analyse the
association between these SNPs and height at age 10, there
is evidence of association for many individual SNPs
(rs3791675 in EFEMP1, rs11830103 in SBNO1, rs6449353
near LCORL, rs11205277 near SF3B4, rs6470764 near
GSDMC, rs7689420 in HHIP, rs11259936 in ADAMTSL3,
rs2856321 in ETV6, rs4800452 near CABLES1, rs1708299 in
Figure 1. Mean birth length and height at 1, 3 and 10 years, by allelic score. Birth lengths and height at exact ages were predicted from a multilevel model that
did not include the allelic score. Mean height differences were calculated as the mean predicted height minus the mean height (separately for boys and girls) for
that age (by allelic score). Bars represent the distribution of the allelic score.
Human Molecular Genetics, 2011, Vol. 20, No. 20 4071JAZF1; Supplementary Material, Table S5), suggesting that
the very small associations observed in each growth period
aggregate to produce real differences of up to 0.6 cm per
allele by this age.
We hypothesized that the associations between the allelic
score and growth may differ according to thirds of birth
length, such that the effect of the allelic score on postnatal
growth would be strongest in those of lower birth length
(i.e. an interaction between allelic score and birth length on
growth). Despite some suggestion that the effect of allelic
score differs by tertile of birth length, there is little statistical
evidence that the coefﬁcients differ (Supplementary Material,
Table S6).
DISCUSSION
Patterns of height and growth are controlled by a number of
mechanisms, which vary from infancy into early adulthood.
Although birth length does appear to have some genetic com-
ponent (13), maternal size (determined by her genes and
environment), behaviours during pregnancy and health and
foetal nutrition are suggested as key determinants of birth
length, whereas genetics, nutrition and illnesses affect
growth more after birth (14). It is thought that growth in the
ﬁrst 2 years of life is more susceptible to environmental inﬂu-
ences than growth later in childhood which is primarily geneti-
cally determined (14). GWASs have now identiﬁed SNPs
robustly associated with adult height (5–12), some of which
have also been shown to be associated with peak height vel-
ocity either infancy or puberty or both (15). To our knowledge,
this is the ﬁrst study to look at the association of these SNPs
with growth trajectories from birth to 10 years, and to
examine the age at which these SNPs begin to inﬂuence
height and height growth.
We have shown that an allelic score derived from a set of
known adult height-associated SNPs (12) is associated with
birth length and with childhood growth from  1 year
onwards. This contrasts with earlier work from the same
cohort showing that socioeconomic inﬂuences on child
height operate primarily through differences in birth length,
but have little effect on postnatal growth (17). These ﬁndings
together suggest that birth length and very early growth appear
to be inﬂuenced by environmental factors and somewhat
by genetic factors, whereas growth later in childhood
appears to be more genetically determined, consistent with
the literature (14).
These ﬁndings suggest that the association observed in pre-
vious work between these SNPs and adult height is not just
due to processes affecting later growth, such as timing, dur-
ation and velocity of the pubertal growth spurt, but that this
genetic component of height is at least operating in part
from before birth and increasingly so from 3 months of age.
In fact whereas the original paper reported that these SNPs
explain  10% of adult height variation, we show that by
age 10 this same set of SNPs already explains  5% of
height variation. We have purposefully modelled growth up
to age 10 only to capture pre-pubertal growth; questions on
age at menarche and Tanner scoring of breast, penis and
pubic hair suggest that at this age the vast majority of the
children (at least 95%) were pre-pubertal. Thus, our results
suggest that these genetic variants are affecting pre-pubertal
growth.
Four loci studied here have previously been shown to have
an interaction with age (HIST1H1D, HHIP, SOCS2 and
DOT1L)( 15). We show supportive evidence for two of these
interactions (although none of these reached statistical signiﬁ-
cance). In our data, rs7689420 (HHIP) is associated with
infancy growth (1–3 years), but not later childhood growth
and rs11107116 (SOCS2) is only associated with later child-
hood growth (3–10 years) and not earlier growth. The pre-
vious studied had shown a HHIP SNP to be associated with
PHV1, but not with PHV2 and the same SOCS2 SNP to be
associated with PHV2 and not PHV1. We cannot claim an
exact replication of the previous study ﬁndings for these
SNPs as the previous study compared associations of these
variants with infant growth and the pubertal growth spurt,
and as noted above, we have purposefully examined associ-
ations with growth from birth to pre-puberty. However, of
the four loci for which they found evidence of an age inter-
action, it was these two for which there is previous biologi-
cally relevant evidence. The HHIP gene is a component of
the hedgehog signal transduction pathway involved in embry-
ogenesis and early development (18) and the SOCS2 has been
shown to have a role in growth hormone signalling, which
may be important in ‘childhood growth’ but not ‘infancy
growth’ (19). We also identiﬁed two other genes with evi-
dence of association only during speciﬁc growth periods.
rs3791675, in EFEMP1, showed association only during the
3–10-year growth period and rs6569648 in L3MBTL3
showed association only with birth length. However, the
differences between associations at different growth periods
for these SNPs were not signiﬁcant and these ﬁndings will
need to be replicated further in future early growth studies.
The differing ages at which individual SNPs show their
effects might suggest that it is inappropriate to use the
allelic score to study genetic growth across time periods.
However, despite the differing effects, our analysis of the
allelic score demonstrates the ages at which the majority of
these SNPs have their effect on growth and shows that
between the ages of 1 and 10 years, this score is associated
with growth rates. Although some observations about the
effects of individual SNPs across ages can be made, this
study lacks power to rigorously investigate this. However,
the score provides a useful and powerful summary of the
association of ‘adult height’ genetic variation with growth in
childhood. Another reason for lack of power for the birth
length analyses speciﬁcally is that measurement error for
length in infancy is greater than for later height measurements.
Post hoc power calculation indicates that the minimal effect
sizes that we would be able to detect, with 90% power and
an alpha of 5%, for the association with allelic score are
0.0068 cm per allele for birth length and 0.0010, 0.0006,
0.0003 and 0.0002 cm per allele per month for the four
growth periods, respectively. The minimal per-allele effect
sizes we would be able to detect with the same power and
alpha for individual SNPs vary between 12 and 20 times
larger than those for the allelic score (depending on a theoreti-
cal minor allele frequency range of 0.5–0.1, Supplementary
Material, Table S7).
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action between birth length and allelic score for the associ-
ation with infancy and childhood growth rates, this
hypothesis is worthy of further investigation in future large
studies of the genetic effects of early childhood growth.
This study demonstrates the involvement of 180 known
adult height SNPs in childhood growth. These SNPs appear
to have some inﬂuence on birth length and are consistently
associated with childhood growth from age 1 year, such that
by age 10 they appear to explain half the variance ( 5%) of
that explained in adults ( 10%).
MATERIALS AND METHODS
ALSPAC participants
ALSPAC is a longitudinal population-based birth cohort that
recruited pregnant women residing in Avon, UK, with an
expected delivery date between 1st April 1991 and 31st
December 1992. A total of 14541 women were enrolled,
with 14062 children born, of which 13988 were alive at
1 year (13617 singletons). The cohort, including its represen-
tativeness, is described in detail on the website http://www.a
lspac.bris.ac.uk and elsewhere (20). Both mothers and children
have been extensively followed from the eighth gestational
week onwards using a combination of self-reported question-
naires, medical records and physical examinations. A
random sub-sample of the children from the last 6 months of
recruitment (‘Children in Focus’ group— 10% of the total
cohort) were invited to clinics between ages 4 months and
5 years; all children were invited to clinics from age 7 years
onwards. Biological samples including DNA have been col-
lected. Ethical approval was obtained from the ALSPAC
Law and Ethics committee and relevant local ethics commit-
tees, and written informed consent provided by all parents.
Genotyping
A total of 9912 subjects were genotyped using the Illumina
HumanHap550 quad genome-wide SNP genotyping platform
by 23 and Me subcontracting the Wellcome Trust Sanger Insti-
tute, Cambridge, UK and the Laboratory Corporation of
America, Burlington, NC, USA. Individuals were excluded
from further analysis on the basis of having incorrect gender
assignments; minimal or excessive heterozygosity (,0.320
and .0.345 for the Sanger data and ,0.310 and .0.330
for the LabCorp data); disproportionate levels of individual
missingness (.3%); evidence of cryptic relatedness (.10%
IBD) and being of non-European ancestry (as detected by a
multidimensional scaling analysis seeded with HapMap 2 indi-
viduals, EIGENSTRAT analysis revealed no additional
obvious population stratiﬁcation and genome-wide analyses
with other phenotypes indicate a low lambda). The resulting
data set consisted of 8365 individuals (84% of those geno-
typed). SNPs with a minor allele frequency of ,1% and
call rate of ,95% were removed. Furthermore, only SNPs
which passed an exact test of Hardy–Weinberg equilibrium
(P . 5 × 10
27) were considered for analysis. Genotypes
were subsequently imputed with MACH 1.0.16 Markov
Chain Haplotyping software, using CEPH individuals from
phase 2 of the HapMap project as a reference set (release 22).
Growth measurements
Length/height data for children were available from several
sources. Birth length (crown-heel) was measured for almost
the whole cohort by ALSPAC staff who visited newborns
soon after birth (median 1 day, range 1–14 days), using a
Harpenden Neonatometer (Holtain Ltd.). From birth to
5 years, measurements are also available for the majority of
the cohort from health visitor records, which form part of stan-
dard child care in the UK. In this cohort, we had up to four
measurements taken on average at 2, 10, 21 and 48 months of
age, which we have demonstrated in previous work to have
good accuracy (21). For a random 10% of the cohort, we also
have measurements from Children in Focus clinics, held
between the ages of 4 months and 5 years of age. At these
clinics, crown-heel length was measured up to 25 months
using a Harpenden Neonatometer (Holtain Ltd.) and from 25
months standing height was measured using a Leicester
Height Measure (Seca). From age 7 to 10 years, all children
were invited to annual clinics, at which standing height
(without shoes) was measured to the last complete mm using
the Harpenden Stadiometer (Holtain Ltd.). Across all ages,
parent-reported child heights are also available from question-
naires.
Modelling of growth trajectories
Growth trajectories were modelled using all available height
measurement sources. Implausible height measurements (.4
SD from the mean for gender- and age-speciﬁc category)
were re-coded as missing (101 measurements from 96 individ-
uals,  0.1% of all available measurements). All other avail-
able measures were used in analyses. To account for the
likely reduced accuracy of parent-reported measurements
(22), a binary indicator of measurement source (research
clinic or health records versus parent-reports from question-
naires) was included in all models.
Individual growth trajectories were estimated using a
mixed-effects linear spline model [two levels: measurement
occasion (age) and individual], ﬁtted using the statistical
package MLwiN version 2.10 (www.cmm.bristol.ac.uk/
MLwiN/index.shtml) (17), using the Stata command runmlwin
(23) (http://www.bristol.ac.uk/cmm/software/runmlwin/). Such
models allow for the change in magnitude and variance of
height over time and use all available data from all eligible
children under a missing at random assumption. They also
allow for individual variation in growth trajectories, since
random effects allow each individual to have different inter-
cepts and slopes. Models for growth between birth and 10
years were constructed for boys and girls combined, with an
interaction between gender and each growth period such that
boys and girls are allowed to have different birth lengths
and growth rates in each period. We identiﬁed three spline
points (four growth periods) that deﬁned periods of approxi-
mately linear growth: between birth and 10 years: 0–3
months, 3–12 months, 12–36 months and 36–120 months.
Full details of the statistical methodology are presented in
Human Molecular Genetics, 2011, Vol. 20, No. 20 4073the Supplementary Material. Over 60000 height measure-
ments were included in the models, with the median number
of individual measurements being 8 (Supplementary Material,
Table S2). The growth trajectory models demonstrated good
ﬁt, with the differences between actual and predicted measure-
ments tending to be small (Supplementary Material, Table S3).
Growth rates were fastest in early infancy and declined
throughout childhood (e.g. growth rate in the ﬁrst 3 months
of life was 3.73 cm/month and between 3 and 10 years of
age was 0.53 cm/month, Table 1).
Statistical analysis
For the individual SNPs, we used the dosages (in terms of esti-
mated number of ‘tall’ alleles) from the imputed data. An
allelic score was constructed by summing across all 180
SNPs the dosages of ‘tall’ alleles, as reported in ref. (12).
Genetic differences in the growth trajectories were esti-
mated by including a statistical interaction between age and
genotype (each SNP and the allelic score) in the multilevel
model, and estimating whether there were differences
between genotypes in terms of the constant term (representing
birth length) and each of the slopes for the growth periods.
Thus, the associated P-values test the null hypothesis of no
difference in birth length or growth in each period per allele,
and the coefﬁcients represent the mean difference in birth
length or growth rate per allele. The effect of genotype on
growth was assumed to be constant across genders, but boys
and girls were allowed different birth lengths and growth
rates in the multilevel model. The only other covariate
included in models was a binary indicator of source of
height measurement (questionnaire versus measured by
ALSPAC clinic staff or health visitors). The genotypes and
allelic score were modelled as additive factors. a ¼ 0.01
(accounting for ﬁve time periods) was taken to be signiﬁcant
for the allelic score and a ¼ 6 × 10
25 (accounting for ﬁve
time periods and 180 SNPs) was taken to be signiﬁcant for
the individual SNPs. For each SNP (and allelic score), the het-
erogeneity of the coefﬁcients between birth length and four
growth periods (in SDs) was assessed using Cochran’s
Q-statistic. For the individual SNPs, a ¼ 0.0003 was taken
to be signiﬁcant (accounting for the 180 SNPs).
Average growth trajectories were plotted for simulated indi-
viduals with the 10th and 90th percentile of the proportion of
tall alleles. We predicted individual heights at exactly 1, 3 and
10 years of age for all children, to enable us to plot heights by
genotype for these exact ages, from a multi-level model that
did not include the genetic terms. These measures of height
at age 10 years were also used to assess the aggregate associ-
ations with individual SNPs (and allelic score), by regressing
against the genotype with sex as a covariate (carried out in
Stata 11.1).
To investigate the hypothesis that the associations of the
allelic score with growth rates would be stronger in those of
smaller birth length, we divided the sample into thirds of
birth length. We ran separate multilevel models for each
third of birth length and examined the effect of the allelic
score within each group. We tested for statistical evidence
of differing effects of allelic score between thirds of birth
length by carrying out a heterogeneity test on the resulting
coefﬁcients.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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